Sector: Health Care
Director information for BRISTOL MYERS SQUIBB
Board as disclosed in the proxy statement filed March 25, 2026. Titles and roles are as stated in that filing and may have changed since.
| Name | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| Christopher S. Boerner, Ph.D. | CEO | 55 | ["Executive Leadership", "Healthcare", "Science/Technology/Innovation", "Financial", "Risk Management", "Sales & Marketing", "International"] | [] | 2026 |
| Deepak L. Bhatt, M.D., M.P.H., M.B.A. | MPH, MBA | 58 | ["Executive Leadership", "Healthcare", "Science/Technology/Innovation", "Risk Management", "International", "Academia/Non-Profit", "Digital"] | ["Audit Committee", "Committee on Directors and Corporate Governance", "Science and Technology Committee"] | 2026 |
| Derica W. Rice | Director; Committee Chair | 61 | ["Healthcare", "Science/Technology/Innovation", "Financial", "Risk Management", "International"] | ["Audit Committee"] | 2026 |
| Julia A. Haller, M.D. | Director; Committee Member; Committee Chair | 71 | ["Executive Leadership", "Healthcare", "Science/Technology/Innovation", "Financial", "Risk Management", "International", "Academia/Non-Profit"] | ["Compensation and Management Development Committee", "Committee on Directors and Corporate Governance", "Science and Technology Committee"] | 2026 |
| Karen H. Vousden, Ph.D. | Director; Additional Member | 68 | ["Healthcare", "Science/Technology/Innovation", "Financial", "Risk Management", "International", "Digital"] | ["Audit Committee", "Committee on Directors and Corporate Governance", "Science and Technology Committee"] | 2026 |
| Manuel Hidalgo Medina, M.D., Ph.D. | Director; Committee Member; Additional Member | 58 | ["Healthcare", "Science/Technology/Innovation", "Risk Management", "International", "Academia/Non-Profit"] | ["Audit Committee", "Committee on Directors and Corporate Governance", "Science and Technology Committee"] | 2026 |
| Michael R. McMullen | Director; Additional Member | 65 | ["Healthcare", "Sales & Marketing", "International"] | ["Audit Committee", "Committee on Directors and Corporate Governance"] | 2026 |
| Paula A. Price | Director; Additional Member; Committee Member | 64 | ["Healthcare", "Science/Technology/Innovation", "Financial", "International"] | ["Audit Committee", "Compensation and Management Development Committee", "Committee on Directors and Corporate Governance"] | 2026 |
| Peter J. Arduini | Director | 61 | ["Executive Leadership", "Healthcare", "Science/Technology/Innovation", "Financial", "Risk Management", "Sales & Marketing", "International"] | [] | 2026 |
| Phyllis R. Yale | Director; Additional Member | 68 | ["Healthcare", "Science/Technology/Innovation", "Financial", "Risk Management", "International"] | ["Compensation and Management Development Committee", "Audit Committee", "Science and Technology Committee"] | 2026 |
| Samit Hirawat, M.D. | Former EVP and Chief Medical Officer, Head of Development | [] | [] | 2026 | |
| Scott Rosen | President and Chief Executive Officer | ["Chief Executive Officer at Bristol Myers Squibb (November 2023-present)", "Board Chair of Bristol Myers Squibb (April 2024-present)", "Board Member of Bristol Myers Squibb (2023-present)", "Executive Vice President, Chief Operating Officer at Bristol Myers Squibb (April 2023-October 2023)", "Executive Vice President, Chief Commercialization Officer at Bristol Myers Squibb (2018-2023)", "Head of International Markets at Bristol Myers Squibb (2017-2018)", "Head of U.S. Commercial Markets at Bristol Myers Squibb (2015-2017)", "Leadership roles at Seattle Genetics, Inc. (2010-2015)", "Marketing leadership roles at Genentech (2002-2010)", "Experience at McKinsey & Company with pharmaceutical and biotechnology clients", "President and Chief Executive Officer at GE Healthcare (2022-present)", "President and Chief Executive Officer at Integra LifeSciences Holdings Corporation (2012-2021)", "President and Chief Operating Officer at Integra LifeSciences Holdings Corporation (2010-2012)", "Corporate Vice President and President of Medication Delivery, Baxter Healthcare (2005-2010)", "15 years at General Electric Healthcare in various management roles"] | ["Compensation and Management Development Committee (Chair)"] | 2026 | |
| Theodore R. Samuels | LID; Director; Additional Member; Committee Chair | 71 | ["Executive Leadership", "Healthcare", "Science/Technology/Innovation", "Financial", "Risk Management", "International", "Academia/Non-Profit", "Digital"] | ["Compliance", "Compensation and Management Development Committee", "Audit Committee", "Committee on Directors and Corporate Governance"] | 2026 |
